Anyone who starts reading about research peptides soon notices that they are rarely presented as tablets. Instead, they are usually described as “injectable peptides” and supplied as a dry powder that is dissolved into a solution in the laboratory. This guide explains why, in general and factual terms. Like everything on this site, it is intended for research and educational purposes only.
Key points
- Peptides are chains of amino acids and are broken down by digestion, so their oral bioavailability is very low.
- Most research peptides are supplied lyophilised (freeze-dried), which improves stability and shelf life.
- In the lab, the powder is reconstituted in a sterile diluent, commonly bacteriostatic water.
- The ratio of diluent to powder sets the final concentration, so accurate calculation matters.
Why aren’t peptides studied as tablets?
The explanation lies in their structure. Peptides are short chains of amino acids, chemically similar to the proteins in food. When swallowed, stomach acid and digestive enzymes break them down into individual amino acids before they can reach the bloodstream intact, so the compound loses the biological activity that researchers want to study. In technical terms, the oral bioavailability of most peptides is very low.
For this reason, many peptides are studied in formulations that bypass the digestive system. This allows a compound to be delivered at a known, consistent concentration, which is a basic requirement of any controlled experiment.
Lyophilised powder: why it is the standard
Most research peptides are supplied as a lyophilised, or freeze-dried, powder. This is not an unfinished “raw” state. Freeze-drying removes water from the compound, which stabilises it and considerably extends its shelf life for as long as it stays dry. It also makes the material more robust during storage and transport.
Reconstitution in the laboratory
Before use in an experiment, the powder is reconstituted, meaning it is dissolved in a sterile liquid. This is often bacteriostatic water: sterile water containing a preservative that inhibits bacterial growth, which is why it is suited to repeated access over several days.
The amount of liquid added relative to the amount of peptide determines the final concentration of the solution. Getting this right is essential for reliable, reproducible data, so we built a free peptide calculator to help with the unit conversions involved in laboratory work. Careful, aseptic handling and an accurately known concentration are what separate dependable research data from noisy results.
Storage
A lyophilised peptide generally remains stable for longer than one that has been reconstituted. For that reason, laboratories typically reconstitute only what is needed for near-term work. Reconstituted solutions are usually kept refrigerated and protected from light.
Which research peptides are supplied this way?
Almost every peptide in our catalogue is supplied as a lyophilised powder for reconstitution. Well-known examples include:
- Tissue-repair research: BPC-157 and TB-500, studied in connection with tendons, joints and other tissues.
- Metabolic research: Retatrutide, an investigational triple agonist of the GLP-1, GIP and glucagon receptors.
- Growth hormone axis: secretagogues such as CJC-1295 and Ipamorelin.
- Skin and neuropeptide research: GHK-Cu, Semax and Selank.
What to remember
The lyophilised, reconstitutable form dominates peptide research simply because it keeps the compound stable and allows it to be used at a known concentration. Every compound sold by Evil Peptides is a research material only: none is approved for therapeutic use, and none is intended for administration to humans or animals. For further reading, see our introduction to peptides and our guide to choosing a research peptide supplier in the UK.
Research use only: this article is general and educational and is not medical advice. All products sold by Evil Peptides are intended solely for laboratory research and are not for human or veterinary use.